Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Ultra-high purity surfactant for biologics and parenteral drug formulations
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Relonchem receives marketing authorization for Moxonidine tablets
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The facility has been classified as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
